• Info
  • Insider Ownership

Insider Trading & Ownership of Sean Michael Smith

Location
Seattle, WA
Summary
The estimated net worth of Sean Michael Smith is at least $14,990 dollars as of 14 Aug 2023. Sean Michael Smith is the Interim CFO, Prin Acct Off of Neoleukin Therapeutics, Inc. and owns shares of Neurogene Inc. (NGNE) stock worth about $15K.
Signature
/s/ Sean Smith
All Insider Reports
All Insider Reports

Notify me when Sean Michael Smith files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Sean Michael Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NGNE Neoleukin Therapeutics, Inc. Interim CFO, Prin Acct Off $14,990 10 Aug 2023

Insider Transactions Reported by Sean Michael Smith:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.